REAL WORLD EVIDENCE NEEDS IN ONCOLOGY:
Non-Prostate Urothelial Cancer
White Paper based on new trial results from ESMO Congress, 20-24 October 2023, Madrid.
In the dynamic landscape of oncology, non-prostate urothelial cancers, encompassing bladder and urinary tract malignancies, present unique challenges in clinical management.
By synthesizing insights from the ESMO 2023 conference and broader oncological discussions in this white paper, we aim to enhance understanding and management of non-prostate urothelial cancer, underlining the escalating importance of RWE in advancing oncological care, particularly for these complex and variable cancers.
To download the white paper please complete the following form: